UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2026
Commission File Number: 001-41569
LANVIN GROUP HOLDINGS LIMITED
4F, 168 Jiujiang Road,
Carlowitz & Co, Huangpu District
Shanghai, 200001, China
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
INCORPORATION BY REFERENCE
This current report on Form 6-K
is incorporated by reference into the registration statement on Form F-3 (No. 333-276476), the post-effective amendment No. 5 to Form F-1 on Form F-3 (No. 333-269150) and the registration statement amendment No. 1 on Form F-3 (No. 333-280891)
of Lanvin Group Holdings Limited and shall be a part thereof from the date on which this Report is furnished, to the extent not superseded
by documents or reports subsequently filed or furnished.
INFORMATION
CONTAINED IN THIS FORM 6-K REPORT
Other Events
On November 10, 2026, Lanvin Group Holdings
Limited (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”)
that the Company is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE Listed Company
Manual because the average closing price of the Company’s ordinary shares (the “Ordinary Shares”), was less than US$1.00
per share over a consecutive 30 trading-day period.
Under Section 802.01C of the NYSE Listed
Company Manual, the Company has a period of six months following receipt of the Notice to regain compliance with the minimum share price
requirement. The Company can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar
month during the cure period, the Ordinary Shares have a closing price of at least US$1.00 per share and an average closing price of at
least US$1.00 per share over the 30 trading-day period ending on the last trading day of that month. If the Company fails to regain compliance
with Section 802.01C by the end of the cure period, the NYSE will commence suspension and delisting procedures with respect to the
Ordinary Shares.
The Company has notified the NYSE, within ten
business days of receipt of the Notice, of its intent to cure the deficiency and regain compliance with the NYSE’s continued listing
standards. There can be no assurance that the Company will be able to regain compliance with Section 802.01C of the NYSE Listed Company
Manual within the cure period or at all.
The Notice has no immediate effect on the listing
or trading of the Ordinary Shares, which will continue to be listed and traded on the NYSE under the symbol “LANV” during
the cure period, subject to the Company’s compliance with the NYSE’s other continued listing standards. The Notice is not
anticipated to impact the Company’s ongoing business operations or its reporting requirements with the U.S. Securities and Exchange
Commission (the “SEC”), and does not conflict with or cause an event of default under any of the Company’s material
debt or other agreements.
On November 13, 2026, the Company issued
a press release announcing its receipt of the Notice. A copy of the press release is furnished as Exhibit 99.1 to this current report
on Form 6-K.
EXHIBIT INDEX
| Exhibit No. |
Description |
| 99.1 |
Press release dated November 13, 2026 |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
LANVIN GROUP HOLDINGS LIMITED |
| |
|
|
| |
By: |
/s/ Xi Luo |
| |
|
Name: |
Xi Luo |
| |
|
Title: |
Chief Financial Officer |
Date: November 13, 2026
Exhibit 99.1
Lanvin Group Receives Continued Listing Standard
Notice from NYSE
Shanghai, China, November 13, 2026 –
Lanvin Group Holdings Limited (NYSE: LANV) (“Lanvin Group” or the “Company”), a global luxury fashion group, today
announced that it received a notice from the New York Stock Exchange (the “NYSE”) on November 10, 2026 that the Company
is not in compliance with the NYSE’s continued listing standard requiring a minimum average closing price of US$1.00 per share for
its ordinary shares over a consecutive 30 trading-day period.
The Company has notified the NYSE within ten business
days of receipt of the notice of its intent to cure the deficiency. Pursuant to the NYSE’s rules, the Company has a six-month period
following receipt of the deficiency letter to regain compliance with the minimum share price requirement.
The Company intends to consider available alternatives,
including but not limited to a reverse stock split that is subject to shareholder approval, if necessary to cure the stock price non-compliance.
The Company can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during
the cure period, the Ordinary Shares have a closing price of at least US$1.00 per share and an average closing price of at least US$1.00
per share over the 30 trading-day period ending on the last trading day of that month.
The NYSE notice has no immediate effect on the
continued listing of Lanvin Group’s ordinary shares on the NYSE and is not anticipated to impact the Company’s ongoing business
operations. The Company’s ordinary shares will continue to be listed and trade on the NYSE under the symbol “LANV” during
this period, subject to the Company’s compliance with the NYSE’s other continued listing requirements.
About Lanvin Group
Lanvin Group is a leading global luxury fashion
group headquartered in Shanghai, China, and Milan, Italy, managing iconic brands worldwide including Lanvin, Wolford, Sergio Rossi
and St. John Knits. Leveraging its unique strategic alliances with industry-leading partners in the luxury fashion sector and its access
to the fastest-growing luxury fashion markets, Lanvin Group strives to expand the global footprint of its portfolio brands and achieve
sustainable growth through strategic investment and extensive operational know-how. Lanvin Group’s ordinary shares are listed on
the New York Stock Exchange under the ticker symbol “LANV”. For more information about Lanvin Group, please visit www.lanvin-group.com,
and to view Lanvin Group’s investor presentation, please visit https://ir.lanvin-group.com.
Forward-Looking Statements
This press release contains “forward-looking
statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act
of 1995. All statements other than statements of historical fact contained in this press release are forward-looking statements, including,
without limitation, statements regarding the Company’s intention and ability to regain compliance with the NYSE’s continued
listing standards within the applicable cure period or at all; the continued listing and trading of the Company’s ordinary shares
on the NYSE; the options the Company may pursue to regain compliance; and the anticipated impact of the NYSE notice on the Company’s
business operations. In some cases, forward-looking statements can be identified by words such as “believe,” “may,”
“will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,”
“should,” “would,” “plan,” “predict,” “potential,” “seek,” “future,”
“outlook” and “project” or the negative of these terms or other similar expressions, although not all forward-looking
statements contain these identifying words.
These forward-looking statements are based on
the Company’s current expectations and assumptions, are not guarantees of future performance and are subject to known and unknown
risks, uncertainties and other factors, many of which are beyond the Company’s control, that could cause actual results to differ
materially from those expressed or implied by these statements, including, without limitation, the market price of the Company’s
ordinary shares and whether it will recover to and remain at or above US$1.00 per share for the required period; whether any option the
Company pursues will be successful; the Company’s ability to continue to satisfy the NYSE’s other continued listing standards;
and the other risks and uncertainties described under “Item 3. Key Information—D. Risk Factors” in the Company’s
annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission
(the “SEC”) on April 30, 2026, and in the Company’s other filings with the SEC.
Forward-looking statements speak only as of the
date of this press release. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise.
Contacts
Media & Investors
Lanvin Group Holdings Limited
Ross Luo
ross.luo@lanvin-group.com
Coco Wang
coco.wang@lanvin-group.com
